Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the mecA Gene in Methicillin-Resistant Staphylococcus aureus: A Novel Approach to Reverse Antibiotic Resistance. Wah Academia Journal of Health and Nutrition, [S. l.], v. 2, n. 2, p. 27–35, 2026. DOI: 10.63954/bantev40. Disponível em: https://wajhn.com/index.php/journal/article/view/77. Acesso em: 21 jul. 2026.